The eMESH 1 Feasibility Study

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

June 30, 2020

Conditions
Atherosclerosis of Autologous Vein Coronary Artery Bypass Graft(s)
Interventions
DEVICE

eSVS Mesh treated saphenous vein graft

During coronary artery bypass graft surgery, one SVG will be randomized to be treated with eSVS Mesh and implanted in the right or left coronary system.

OTHER

Control saphenous vein graft

During coronary artery bypass graft surgery, one SVG will be randomized to be the control (no eSVS Mesh) and implanted in the right or left coronary system.

Trial Locations (15)

3010

RECRUITING

University Hospital of Bern, Bern

10075

RECRUITING

Lenox Hill Hospital, New York

30308

RECRUITING

Emory University Hospital Midtown, Atlanta

30501

RECRUITING

Northeast Georgia Heart Center, Gainesville

55905

RECRUITING

Mayo Clinic / St. Mary's Hospital, Rochester

07450

RECRUITING

The Valley Hospital, Ridgewood

Unknown

RECRUITING

General University Hospital, Prague

RECRUITING

Hospital na Homolce, Prague

ACTIVE_NOT_RECRUITING

University Hospital Kralovske Vinohrady, Prague

RECRUITING

C.H.U. Dupuytren, Limoges

RECRUITING

Bordeaux University Hospital, Pessac

RECRUITING

Lancisi Hospital, Ancona

RECRUITING

Heart Hospital - G. Monasterio Tuscany Foundation for Health & Research, Massa

RECRUITING

Catharina Ziekenhuis, Eindhoven

SW3 6NP

RECRUITING

Royal Brompton Hospital, London

Sponsors
All Listed Sponsors
lead

Kips Bay Medical, Inc.

INDUSTRY